VAI Trademark

Trademark Overview

On Friday, August 13, 2021, a trademark application was filed for VAI with the United States Patent and Trademark Office. The USPTO has given the VAI trademark a serial number of 90882005. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, August 14, 2024. This trademark is owned by Antares Pharma, Inc.. The VAI trademark is filed in the Medical Instrument Products category with the following description:

injection device for pharmaceuticals and biopharmaceuticals
vai

General Information

Serial Number90882005
Word MarkVAI
Filing DateFriday, August 13, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, August 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2022

Trademark Statements

Goods and Servicesinjection device for pharmaceuticals and biopharmaceuticals

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, October 4, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAntares Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628
Party NameAntares Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628

Trademark Events

Event DateEvent Description
Tuesday, August 17, 2021NEW APPLICATION ENTERED
Monday, October 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 14, 2022ASSIGNED TO EXAMINER
Tuesday, May 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 1, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 21, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 21, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, February 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 16, 2023SOU EXTENSION 1 FILED
Thursday, February 16, 2023SOU EXTENSION 1 GRANTED
Wednesday, August 16, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024SOU EXTENSION 3 GRANTED
Tuesday, February 13, 2024SOU EXTENSION 3 FILED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 16, 2023SOU EXTENSION 2 FILED
Wednesday, August 16, 2023SOU EXTENSION 2 GRANTED
Friday, August 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU EXTENSION 4 GRANTED
Wednesday, August 14, 2024SOU EXTENSION 4 FILED
Thursday, January 16, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

biopharmaceuticals pharmaceuticals device injection